Artivion, Inc. Overview
Pro stress-test →Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. The company provides specialized solutions for treating aortic disease, heart valve disease, aortic aneurysms, and dissections through four major product families: aortic stent grafts, On-X mechanical heart valves, surgical sealants, and preserved cardiac/vascular tissues.
Strategic Profile
Pro stress-test →Recent acquisitions and partnerships have empowered the company to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves and aortic stents and stent grafts. The company focuses on aortic stent grafts, On-X mechanical valves, surgical sealants and preserved tissues, investing $31M in R&D while navigating intense competition, complex global regulations and supply-chain risks across North America, Europe, APAC and Latin America.
Competitive Landscape
Pro stress-test →Artivion faces intense competition from large device makers and other tissue processors in the cardiac and vascular medical device space. Key competitors include Medtronic (aortic and vascular division), Abbott, and Edwards Lifesciences in heart valve markets. Artivion differentiates through its specialized aortic-centric focus and integrated portfolio combining stent grafts, mechanical valves, surgical sealants, and preserved tissues.
Industry Context
Artivion, Inc. operates in Cardiovascular Medical Devices / Cardiac & Vascular Surgery.
Key facts
Founded: 1984 · Headquarters: Kennesaw, Georgia, USA · Employees: 1,250-1,600 · Revenue: $423-435M